TR201900160T4 - Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler. - Google Patents

Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler. Download PDF

Info

Publication number
TR201900160T4
TR201900160T4 TR2019/00160T TR201900160T TR201900160T4 TR 201900160 T4 TR201900160 T4 TR 201900160T4 TR 2019/00160 T TR2019/00160 T TR 2019/00160T TR 201900160 T TR201900160 T TR 201900160T TR 201900160 T4 TR201900160 T4 TR 201900160T4
Authority
TR
Turkey
Prior art keywords
detecting
assays
amount
drug antibody
methods
Prior art date
Application number
TR2019/00160T
Other languages
English (en)
Inventor
GRABERT Ryan
Richards Susan
Theobald Valerie
Xu Yuanxin
Zoghbi Jad
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of TR201900160T4 publication Critical patent/TR201900160T4/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Antikorların (örneğin anti-ilaç antikorları) saptanmasına yönelik yöntemler ve kitlerdir. Bu tür yöntemler ve kitler, kan, plazma ve serum gibi insan vücut sıvılarında örneğin anti-ilaç antikorlarının saptanmasına izin verir.
TR2019/00160T 2014-02-11 2015-02-11 Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler. TR201900160T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461938556P 2014-02-11 2014-02-11

Publications (1)

Publication Number Publication Date
TR201900160T4 true TR201900160T4 (tr) 2019-02-21

Family

ID=52684652

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00160T TR201900160T4 (tr) 2014-02-11 2015-02-11 Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler.

Country Status (19)

Country Link
US (4) US9759732B2 (tr)
EP (4) EP3422001B1 (tr)
CN (1) CN106164670B (tr)
AU (2) AU2015217261B2 (tr)
CA (1) CA2939080A1 (tr)
CY (1) CY1121341T1 (tr)
DK (1) DK3105592T3 (tr)
ES (1) ES2705403T3 (tr)
HR (1) HRP20190026T1 (tr)
HU (1) HUE041669T2 (tr)
LT (1) LT3105592T (tr)
MX (2) MX2016010413A (tr)
PL (1) PL3105592T3 (tr)
PT (1) PT3105592T (tr)
RS (1) RS58212B1 (tr)
SG (2) SG10201906750XA (tr)
SI (1) SI3105592T1 (tr)
TR (1) TR201900160T4 (tr)
WO (1) WO2015123315A1 (tr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9759732B2 (en) 2014-02-11 2017-09-12 Genzyme Corporation Assays for detecting the presence or amount of an anti-drug antibody
EP2982987A1 (en) * 2014-08-08 2016-02-10 Proteomika, S.L. Lateral flow immunoassays for the detection of antibodies against biological drugs
US9927443B2 (en) * 2015-04-10 2018-03-27 Conquerab Inc. Risk assessment for therapeutic drugs
RU2725142C2 (ru) * 2015-10-15 2020-06-30 Биокон Лимитед Способ обнаружения нейтрализующих антител против рекомбинантного человеческого инсулина в сыворотке крови человека
EP3391050B1 (en) * 2015-12-16 2020-09-16 F. Hoffmann-La Roche AG Three-step acid dissociation enzyme linked immunosorbent (tadelis) assay
US9903866B2 (en) 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
EP3239711B1 (en) * 2016-04-27 2019-12-25 JIMRO Co., Ltd. Method for measuring anti-drug antibody
CN114773471A (zh) 2016-10-20 2022-07-22 天境生物科技(上海)有限公司 新的cd47单克隆抗体及其应用
EP3665203B1 (en) * 2017-08-08 2022-06-29 F. Hoffmann-La Roche AG Method for determining anti-drug antibodies in a minipig sample
WO2019105916A1 (en) * 2017-11-29 2019-06-06 F. Hoffmann-La Roche Ag Target interference suppressed anti-drug antibody assay
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
IL277890B2 (en) * 2018-04-11 2024-03-01 Regeneron Pharma Methods for quantification of IL-33
US12055551B2 (en) * 2018-07-10 2024-08-06 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ADA) immunoassay
EP3830579A1 (en) * 2018-08-03 2021-06-09 Bristol-Myers Squibb Company Methods for detecting anti-drug antibodies
WO2020214795A1 (en) * 2019-04-16 2020-10-22 Laboratory Corporation Of America Holdings Methods and systems for detecting antibodies by surface plasmon resonance
KR102695013B1 (ko) 2019-04-24 2024-08-13 삼성전자주식회사 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법
CN112285351A (zh) * 2019-07-22 2021-01-29 上海益诺思生物技术股份有限公司 一种抗IgE单抗的ELISA检测方法
CA3148161A1 (en) * 2019-09-05 2021-03-11 Adverum Biotechnologies Anti-drug antibody assay
CN111171141A (zh) * 2020-01-20 2020-05-19 苏州药明康德新药开发有限公司 聚乙二醇在临床前安全性评价中的应用
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术（北京）有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
US20210341487A1 (en) * 2020-05-01 2021-11-04 Regeneron Pharmaceuticals, Inc. Neutralizing antibody assay for therapeutic proteins
JP7478040B2 (ja) * 2020-06-25 2024-05-02 シスメックス株式会社 Ａβペプチドの測定方法及びその方法に用いられる試薬組成物
EP4229391A1 (en) * 2020-10-14 2023-08-23 I-Mab Biopharma Co., Ltd. Methods for mitigating interference by therapeutic anti-cd47 antibodies in pre-transfusion assays
JP7062803B1 (ja) * 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
EP4448570A1 (en) 2021-12-14 2024-10-23 CDR-Life AG Dual mhc-targeting t cell engager
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
TW202426498A (zh) 2022-09-09 2024-07-01 德商拜耳廠股份有限公司 Ccr8抗體之醫藥用途及給藥計劃
WO2024056758A1 (en) 2022-09-14 2024-03-21 Cdr-Life Ag Mage-a4 peptide dual t cell engagers
WO2024064044A1 (en) * 2022-09-23 2024-03-28 Merck Sharp & Dohme Llc Neutralization antibody assay method
CN115561355B (zh) * 2022-09-26 2024-04-30 重庆迪纳利医药科技有限责任公司 羧肽酶g2的中和抗体检测方法以及基于lc-ms/ms的检测系统
CN116699147A (zh) * 2023-08-04 2023-09-05 军科正源（北京）药物研究有限责任公司 检测总IgE含量的方法以及相关试剂盒
CN117849327A (zh) * 2024-03-06 2024-04-09 军科正源（北京）药物研究有限责任公司 用于检测苏金单抗抗药性抗体的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006515A1 (en) * 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
US5187065A (en) * 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
ES2498377T3 (es) * 2006-03-09 2014-09-24 F. Hoffmann-La Roche Ag Ensayo de anticuerpos antifármaco
CA2686206A1 (en) * 2007-05-07 2008-11-13 Wyeth Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
AU2008348252A1 (en) * 2008-01-15 2009-07-23 Stichting Sanquin Bloedvoorziening Method and kits for detecting antibodies against therapeutic antibodies
JP2010078374A (ja) 2008-09-24 2010-04-08 Olympus Corp 抗赤血球抗体の検出方法
US7799532B2 (en) * 2008-11-12 2010-09-21 Hemopet Detection and measurement of thyroid hormone autoantibodies
CN103502815B (zh) 2011-02-17 2015-09-23 雀巢产品技术援助有限公司 检测针对抗-TNFα药物的自身抗体的测定法
EP2823310B1 (en) * 2012-03-08 2018-06-20 F.Hoffmann-La Roche Ag Multiplexed chromatography-immunoassay method for the characterization of circulating immune complexes
BR112015032960B1 (pt) * 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
US9759732B2 (en) 2014-02-11 2017-09-12 Genzyme Corporation Assays for detecting the presence or amount of an anti-drug antibody

Also Published As

Publication number Publication date
CY1121341T1 (el) 2020-05-29
US20150226758A1 (en) 2015-08-13
CA2939080A1 (en) 2015-08-20
LT3105592T (lt) 2019-01-25
MX2016010413A (es) 2016-11-30
CN106164670B (zh) 2019-06-14
EP3422001A1 (en) 2019-01-02
US11215623B2 (en) 2022-01-04
HUE041669T2 (hu) 2019-05-28
PT3105592T (pt) 2019-01-23
US20180088140A1 (en) 2018-03-29
SG10201906750XA (en) 2019-09-27
RS58212B1 (sr) 2019-03-29
AU2015217261A1 (en) 2016-09-08
US20240288454A1 (en) 2024-08-29
EP4137816A1 (en) 2023-02-22
AU2015217261B2 (en) 2020-08-27
EP3667321B1 (en) 2022-07-27
ES2705403T3 (es) 2019-03-25
EP3105592A1 (en) 2016-12-21
US9759732B2 (en) 2017-09-12
MX2020009021A (es) 2020-10-12
PL3105592T3 (pl) 2019-04-30
EP3105592B1 (en) 2018-10-17
SI3105592T1 (sl) 2019-02-28
US20220187327A1 (en) 2022-06-16
HRP20190026T1 (hr) 2019-02-22
EP3667321A1 (en) 2020-06-17
DK3105592T3 (en) 2019-02-04
WO2015123315A1 (en) 2015-08-20
SG11201606291VA (en) 2016-08-30
EP3422001B1 (en) 2020-03-25
CN106164670A (zh) 2016-11-23
US11927596B2 (en) 2024-03-12
AU2020264316A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
TR201900160T4 (tr) Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler.
PH12019501146A1 (en) Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
CY1121723T1 (el) Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων
MX2019007653A (es) Métodos para la optimización de ensayos rápidos de susceptibilidad antimicrobiana.
PH12019501837A1 (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
MX2016013261A (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
EA201792289A1 (ru) Способы обнаружения агглютинации и композиции для их осуществления
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
EA201700208A1 (ru) Способ и устройство для обнаружения малярии
EA201890739A1 (ru) Анти-s100a8 для лечения лейкемии
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
EP3721229A4 (en) LATERAL FLOW ASSAY AND METHOD OF DETECTING HIGH CONCENTRATION ANALYTES
BR112016028838A2 (pt) anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer
BR112018013381A2 (pt) anticorpo especificamente ligante a antígenos derivados de miobacteria ou fragmento ligante a antígeno do mesmo
SG10201806729VA (en) Novel assay to detect human periostin
WO2014151290A3 (en) Assay for predictive biomarkers
DK3143403T3 (da) Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
SG10201901836PA (en) Test strip assembly
MX2017008748A (es) Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana.
TH183177B (th) วิธีตรวจวัดเป้าหมายของการตรวจและเครื่องมือตรวจวัดทางภูมิคุ้มกัน และมอโนคลอนอลแอนติบอดี
TH1601000764A (th) แอนติบอดีตามตัวยับยั้งพลาสมิโนเจนแอคติเวเตอร์-1 (pai-1) และการใช้ของสิ่งนั้น